Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Quercetin and other plant flavonols show anti-SARS-CoV-2 activity

Quercetin and other plant flavonols show anti-SARS-CoV-2 activity

Booster vaccine provides similar protection in SARS-CoV-2 naive and convalescent individuals

Booster vaccine provides similar protection in SARS-CoV-2 naive and convalescent individuals

4% patients with COVID-19 shed fecal viral RNA 10 months after diagnosis

4% patients with COVID-19 shed fecal viral RNA 10 months after diagnosis

Impact of COVID-19 vaccination on anti-nucleocapsid antibody levels

Impact of COVID-19 vaccination on anti-nucleocapsid antibody levels

Study demonstrates increased incidence of SARS-CoV-2 Omicron breakthrough infection in cancer patients

Study demonstrates increased incidence of SARS-CoV-2 Omicron breakthrough infection in cancer patients

How does SARS-CoV-2 infection affect the diversity of the gut microbiome?

How does SARS-CoV-2 infection affect the diversity of the gut microbiome?

Efficacy of vaccination against SARS-CoV-2 Omicron BA.1 and BA.2 sublineages in Sweden

Efficacy of vaccination against SARS-CoV-2 Omicron BA.1 and BA.2 sublineages in Sweden

Continual genomic surveillance in Africa provides insights into evolving SARS-CoV-2 pandemic

Continual genomic surveillance in Africa provides insights into evolving SARS-CoV-2 pandemic

The diversity of transcriptional targets between four different coronavirus nsp1 proteins

The diversity of transcriptional targets between four different coronavirus nsp1 proteins

Interleukin-6 levels predict early withdrawal of COVID-19 patients from mechanical ventilation

Interleukin-6 levels predict early withdrawal of COVID-19 patients from mechanical ventilation

Antibody escape in SARS-CoV-2 Omicron spike protein

Antibody escape in SARS-CoV-2 Omicron spike protein

Study demonstrates that a low-dose, bivalent, unmodified mRNA vaccine against SARS-CoV-2 is highly efficacious

Study demonstrates that a low-dose, bivalent, unmodified mRNA vaccine against SARS-CoV-2 is highly efficacious

Booster dose of BNT162b2 mRNA vaccine induces a high cross-neutralizing response against SARS-CoV-2 variants

Booster dose of BNT162b2 mRNA vaccine induces a high cross-neutralizing response against SARS-CoV-2 variants

Rhinovirus the main virus co-circulating with SARS-CoV-2 in children

Rhinovirus the main virus co-circulating with SARS-CoV-2 in children

COVID-19 mRNA vaccine protects against ICU admission for 1 year

COVID-19 mRNA vaccine protects against ICU admission for 1 year

Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants

Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants

SARS-CoV-2 spike protein disrupts lipid metabolism resulting in liver, heart & kidney damage

SARS-CoV-2 spike protein disrupts lipid metabolism resulting in liver, heart & kidney damage

COVID-19 diagnosis in pregnancy and the postnatal period: Study

COVID-19 diagnosis in pregnancy and the postnatal period: Study

CRISPR-based detection of SARS-CoV-2 RNA directly from patient swabs

CRISPR-based detection of SARS-CoV-2 RNA directly from patient swabs

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.